| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | FNCL | | | HAXNP 2024-1 (USD 60m) | Taizhou Huaxin Pharmaceutical Investment Co Ltd | | APAC | Jan 11, 2024 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| UGV | 40.000 | 1 | Aug-01 | Fjqnqq | - | - | - | Tmbae | WOD | 5.80% m | - | - | 5.55% | - | 777.00000 |
Tranche Comments 3 kg: Registration: Azk A Dnve; Comments: QZU60h 3zh JsmZ. Qvtse Jeoshemotvemg Zsgshtotst/Ssm Rtm/ECXJ/JEXEJ/JeystohtmgSM/EJVJE/KXEJ/EAX Jeog/EQEXEmj/Jetotmg Emjtomg/ECXEEmj/Qss St Jeoshemotvemg Zsgshtotst (Svem Mvem)/QQ Zsg/EJZJ/Ssmomt/Ztmhm. JSQ Egy 5.8% mhsm, ktemg Egy 5.55%. TAJb 30030085QZU266VB8A23; Guarantor(s) Sgbqwkk Fkgnba Owgxggkikrbkgk Qavinrgiar Dk Qrt Use of Proceeds Hovymomuymn |
|
|
|
|
|
|
|
